Read More Pharma Industry News Myopia drug breakthrough: Sydnexis’ SYD-101 approved in Europe, Ryjunea launch next Sydnexis, Inc., a privately held U.S. biopharmaceutical company, secured a critical regulatory victory on June 5, 2025, with… byPallavi MadhirajuJune 6, 2025